Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Schneider

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 2018
CIM Journal Club: Gene therapy for spinal muscular atrophy Comment on Mendell et al. N Engl J Med 2017;377:1713-22Raphael Schneider
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2009
Neuronal degeneration in a viral model of multiple sclerosisRaphael Schneider
Science Signaling|April 22, 2010
T cells with commitment issuesRaphael Schneider
Multiple Sclerosis and Related Disorders|March 20, 2015
CD20+ T cells in multiple sclerosisRaphael Schneider
Frontiers in Neurology|September 14, 2013
Autoantibodies to Potassium Channel KIR4.1 in Multiple SclerosisRaphael Schneider
Cancer Biology & Therapy|December 30, 2010
Microvilli expressed on glioma cells keep cytotoxic cells at a distanceFatma Zaguia, Raphael Schneider
Current Neurology and Neuroscience Reports|October 27, 2022
Bruton's Tyrosine Kinase Inhibition in Multiple SclerosisRaphael Schneider, Jiwon Oh
Neurology|June 8, 2023
A Birth Year Cohort and What It Can Reveal About Lipid Mediators as Putative Biomarkers of Progression in Multiple SclerosisDalia Rotstein, Raphael Schneider
Neurology|May 30, 2012
Journal club: Intrathecal effects of daclizumab treatment of multiple sclerosisRaphael Schneider, Nathalie Arbour
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 22, 2013
Glutamate excitotoxicity in the cerebellum mediated by IL-1βAlma Nazlie Mohebiany, Raphael Schneider
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 2018
CIM Journal Club: Gene therapy for spinal muscular atrophy Comment on Mendell et al. N Engl J Med 2017;377:1713-22Raphael Schneider
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2009
Neuronal degeneration in a viral model of multiple sclerosisRaphael Schneider
Science Signaling|April 22, 2010
T cells with commitment issuesRaphael Schneider
Multiple Sclerosis and Related Disorders|March 20, 2015
CD20+ T cells in multiple sclerosisRaphael Schneider
Frontiers in Neurology|September 14, 2013
Autoantibodies to Potassium Channel KIR4.1 in Multiple SclerosisRaphael Schneider
Cancer Biology & Therapy|December 30, 2010
Microvilli expressed on glioma cells keep cytotoxic cells at a distanceFatma Zaguia, Raphael Schneider
Current Neurology and Neuroscience Reports|October 27, 2022
Bruton's Tyrosine Kinase Inhibition in Multiple SclerosisRaphael Schneider, Jiwon Oh
Neurology|June 8, 2023
A Birth Year Cohort and What It Can Reveal About Lipid Mediators as Putative Biomarkers of Progression in Multiple SclerosisDalia Rotstein, Raphael Schneider
Neurology|May 30, 2012
Journal club: Intrathecal effects of daclizumab treatment of multiple sclerosisRaphael Schneider, Nathalie Arbour
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 22, 2013
Glutamate excitotoxicity in the cerebellum mediated by IL-1βAlma Nazlie Mohebiany, Raphael Schneider
Pageof 9